Kazunao Kondo Selected Research

N- (3- (4- Oxo- 3,4- dihydro- phthalazin- 1- yl)phenyl)- 4- (morpholin- 4- yl) butanamide methanesulfonate monohydrate

11/2004

Neuroprotective effects of ONO-1924H, an inhibitor of poly ADP-ribose polymerase (PARP), on cytotoxicity of PC12 cells and ischemic cerebral damage.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kazunao Kondo Research Topics

Disease

3	Hemorrhage 08/2016 - 04/2002
3	Ischemia 01/2008 - 04/2002
3	Thrombosis (Thrombus) 11/2004 - 04/2002
2	Mental Disorders (Mental Disorder) 01/2022 - 01/2010
2	Hyperplasia 09/2005 - 09/2005
2	Cerebral Hemorrhage 04/2004 - 04/2002
2	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 04/2004 - 08/2002
1	Priapism 01/2022
1	Hypoglycemia (Reactive Hypoglycemia) 03/2017
1	Hypertension (High Blood Pressure) 03/2017
1	Bradycardia 03/2017
1	Phenylketonurias (Phenylketonuria) 01/2011
1	Intermittent Claudication 01/2011
1	Dopa-responsive Dystonia 01/2010
1	Inflammation (Inflammations) 03/2009
1	Arteriosclerosis 03/2009
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 10/2005
1	Neutropenia 09/2005
1	Ischemic Stroke 11/2004
1	Stroke (Strokes) 04/2004
1	Brain Ischemia (Cerebral Ischemia) 04/2004
1	Cerebral Infarction 08/2002
1	Edema (Dropsy) 08/2002
1	Rupture 02/2002
1	Acute Coronary Syndrome 01/2002

Drug/Important Bio-Agent (IBA)

3	sepiapterin reductaseIBA 01/2022 - 01/2011
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2010
2	Dopamine (Intropin)FDA LinkGeneric 01/2011 - 01/2010
2	EnzymesIBA 01/2011 - 01/2010
2	P-SelectinIBA 09/2005 - 09/2005
2	Fibrinolytic Agents (Antithrombotic Agents)IBA 04/2005 - 04/2002
2	Heparin (Liquaemin)FDA LinkGeneric 04/2004 - 04/2002
2	Matrix Metalloproteinases (MMPs)IBA 04/2004 - 02/2002
2	Rose BengalIBA 04/2003 - 04/2002
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2022
1	Amino Acids FDA Link 01/2022
1	sapropterin (tetrahydrobiopterin)FDA Link 01/2022
1	Cyclic NucleotidesIBA 01/2022
1	Guanosine Monophosphate (5' Guanylic Acid)IBA 01/2022
1	BiopterinsIBA 01/2022
1	ReninIBA 03/2017
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 03/2017
1	Pharmaceutical PreparationsIBA 08/2016
1	6-pyruvoyltetrahydropterin synthase (PTPS)IBA 01/2011
1	Phosphodiesterase InhibitorsIBA 01/2011
1	Cilostazol (Pletal)FDA LinkGeneric 01/2011
1	GTP Cyclohydrolase (GTP Cyclohydrolase I)IBA 01/2010
1	Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA 01/2010
1	Nitric Oxide DonorsIBA 01/2008
1	CytokinesIBA 10/2005
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2005
1	LigandsIBA 09/2005
1	Sialyl Lewis X AntigenIBA 09/2005
1	Galactosylceramides (Galactocerebrosides)IBA 09/2005
1	Phytic Acid (Inositol Hexaphosphate)IBA 09/2005
1	Sulfoglycosphingolipids (Sulfatides)IBA 09/2005
1	Hemostatics (Antihemorrhagics)IBA 04/2005
1	N- (3- (4- Oxo- 3,4- dihydro- phthalazin- 1- yl)phenyl)- 4- (morpholin- 4- yl) butanamide methanesulfonate monohydrateIBA 11/2004
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 11/2004
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 11/2004
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 04/2004
1	Tissue Plasminogen Activator (Alteplase)FDA Link 04/2004
1	FlavonesIBA 04/2003
1	Sodium-Hydrogen ExchangersIBA 08/2002
1	SM 20220IBA 08/2002
1	Singlet OxygenIBA 04/2002
1	OxidesIBA 02/2002
1	CholesterolIBA 02/2002
1	Platelet Membrane Glycoprotein IIbIBA 01/2002

Therapy/Procedure

2	Thrombolytic Therapy 04/2004 - 04/2002
1	Transplantation 03/2009
1	Therapeutics 04/2004